- $27.01m
- $152.93m
- CNY12.56bn
Chinese healthcare platform 111 Inc's Q3 revenue drops amid model shift
Brief: 111, Inc. Announces ADS Ratio Change
Brief: 111, Inc. Announces Receipt of Notification from Nasdaq
Founders Currently Beneficially Own 42.7% Of Total Issued Share Capital Of Company
Brief: 111, Inc. Says Qtrly Loss Per ADS RMB 2.48
Brief: 111 Announces Receipt Of Withdrawal Of Going Private Proposal
Brief: 111, Inc. Announces Third Quarter 2023 Unaudited Financial Results
Brief: 111 Inc Reports Q2 Revenue Rose 14.5 Percent To RMB 3.5 Billion
Brief: 111, Inc Says Q1 Revenue Rose 23.9% TO RMB 3.7 Bln
Brief: 111 Announces Fourth Quarter 2022 Financial Results
U.S. STOCKS ON THE MOVE-Apparel stocks, copper and silver miners
U.S. STOCKS ON THE MOVE-Alphabet, Moderna, chip stocks
U.S. STOCKS ON THE MOVE-Eli Lilly, Payment firms, Big tech
111 Inc begins selling Pfizer's COVID-19 treatment in China; shares up
China health app starts online sales of Pfizer's Paxlovid for COVID treatment (updated)
China's 111.inc app starts retail sales of Pfizer's Paxlovid for COVID treatment
Brief: 111, Inc. Reports Q3 Loss Per Share Of $0.16
U.S. STOCKS ON THE MOVE-OFS Credit, Nike, Elevance Health
U.S. STOCKS ON THE MOVE-CytoSorbents, Tapestry, Wayfair